Humana stock tumbles to pace S&P 500 losers after slashing Medicare Advantage membership growth view

Shares of Humana Inc. HUM, -19.64% tumbled 13.0% toward a three-month debased successful day trading Thursday, to gait the S&P 500's SPX, +0.22% decliners, aft the wellness security services institution slashed its full-year rank estimation for its Medicare Advantage products. Humana's banal was headed for the biggest one-day selloff since it slid 13.9% connected March 16, 2020. Humana disclosed earlier Thursday that it present expects 2022 nett rank maturation for its idiosyncratic Medicare Advantage products of 150,000 to 200,000 members, down from a erstwhile estimation of 325,000 to 375,000 owed chiefly to "higher than anticipated terminations" during the yearly predetermination period, combined with expectations of higher than primitively expected terminations for the remainder of 2022. The institution expects 2022 adjusted net per stock of astir $20.50, compared with the FactSet statement of $20.53. Meanwhile, for the Humana Premier Rx Plan (PDP), the institution present estimates a nett rank diminution of 125,000 members successful 2022, compared with erstwhile estimates of a nonaccomplishment of "a fewer 100 1000 members," citing better-than-expected income of the Walmart Value program and lower-than-anticipated terminations. Among different wellness insurers, shares of UnitedHealth Group Inc. UNH, -4.40% dropped 1.9% and Anthem Inc. ANTM, -4.18% slumped 1.6%.